Provectus Biopharmaceuticals, Inc. reports

Location
Knoxville, TN
Fiscal year end
December 31
Provectus Biopharmaceuticals, Inc. has filed 1,033 SEC EDGAR filings since 3/31/2000
Form type Sec Links Description Filing date Reporting date
10-K/A Report | Data 10-K/A May 16, 2025 Dec 31, 2024
10-K Report | Data Mar 28, 2025 Dec 31, 2024
10-K/A Report | Data Apr 29, 2024 Dec 31, 2023
10-K Report | Data Mar 28, 2024 Dec 31, 2023
10-K Report | Data Mar 30, 2023 Dec 31, 2022
10-K Report | Data Mar 29, 2022 Dec 31, 2021
10-K Report | Data Mar 2, 2021 Dec 31, 2020
10-K Report | Data Mar 5, 2020 Dec 31, 2019
10-K/A Report May 9, 2019 Dec 31, 2018
10-K Report | Data Mar 7, 2019 Dec 31, 2018
10-K Report | Data Mar 23, 2018 Dec 31, 2017
10-K Report | Data FORM 10-K Mar 31, 2017 Dec 31, 2016
10-K Report | Data FORM 10-K Mar 30, 2016 Dec 31, 2015
10-K Report | Data 10-K Mar 12, 2015 Dec 31, 2014
10-K Report | Data 10-K Mar 13, 2014 Dec 31, 2013